Picard Medical, Inc. (PMI)
| Market Cap | 549.66M |
| Revenue (ttm) | 3.03M |
| Net Income (ttm) | -27.46M |
| Shares Out | 72.32M |
| EPS (ttm) | -3.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,270,232 |
| Open | 7.10 |
| Previous Close | 7.15 |
| Day's Range | 6.95 - 7.75 |
| 52-Week Range | 4.19 - 7.75 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PMI
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona. Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc. [Read more]
Financial Performance
In 2024, Picard Medical's revenue was $4.39 million, a decrease of -12.93% compared to the previous year's $5.04 million. Losses were -$23.74 million, 31.9% more than in 2023.
Financial numbers in USD Financial StatementsNews
Picard Medical Reports Second Quarter 2025 Financial Results
TUSCON, Ariz., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world's first U.S. and Ca...
Picard Announces Appointment of Two New Members to its Board of Directors
Appointments strengthen Picard's Board with proven expertise in capital markets and global MedTech leadership Appointments strengthen Picard's Board with proven expertise in capital markets and global...
Picard Medical, Inc. Announces Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial publi...
Picard Medical, Inc. Announces Presentation at H.C. Wainwright Global Investment Conference
TUCSON, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that Patrick NJ Schnegelsberg, Chief Executive Officer, will pr...
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares ...
U.S. IPO Weekly Recap: Quiet Week As IPO Market Gears Up For A Busy Fall
Four small issuers and two SPACs priced offerings in the past week, and a few names joined the pipeline. The largest deals of the week came from the pair of blank check IPOs. There are no IPOs current...
Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering
TUCSON, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCar...
Philip Morris shares fall 7% as Q2 revenue misses
Philip Morris International (PMI), the world's largest tobacco company by market capitalization, reported second-quarter results that fell short of analyst revenue expectations, leading to a 7% drop i...
Picard Medical Seeks IPO On Dropping Revenue And High Valuation
Picard Medical, Inc. has filed to raise $17 million in an IPO. Management's valuation assumptions are extreme, with the IPO seeking a Price/Sales multiple far above industry norms. Picard faces signif...
SynCardia artificial heart maker Picard Medical plans to go public
Picard Medical, which owns and operates the implant manufacturer SynCardia, aims to list on the New York Stock Exchange under the ticker PMI.
Artificial heart maker Picard Medical files for a $12 million IPO
Picard Medical, which makes and sells implantable total artificial hearts under the brand SynCardia, filed on Tuesday with the SEC to raise up to $12 million in an initial public offering.
Picard Medical IPO Registration Document (S-1)
Picard Medical has filed to go public with an IPO on the NYSE American.